313: Biotech layoffs, founder-focused VC, & a big pharma exit
The Readout Loud
00:00
Analysis of Pfizer's R&D Chief Departure and Its Implications for the Company
Debate over the implications of Pfizer's R&D chief leaving after 15 years, questioning the impact on the company's performance in a post-COVID world and its ability to address challenges in pipeline strength and growth strategies.
Transcript
Play full episode
